Skip to main content
Journal cover image

Neuroprotective therapy for acute ischaemic stroke: down, but not out.

Publication ,  Journal Article
Goldstein, LB
Published in: Lancet
February 7, 2004

Duke Scholars

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

February 7, 2004

Volume

363

Issue

9407

Start / End Page

414 / 415

Location

England

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Research Design
  • Randomized Controlled Trials as Topic
  • Neuroprotective Agents
  • Magnesium Sulfate
  • Humans
  • General & Internal Medicine
  • Acute Disease
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B. (2004). Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet, 363(9407), 414–415. https://doi.org/10.1016/S0140-6736(04)15522-0
Goldstein, Larry B. “Neuroprotective therapy for acute ischaemic stroke: down, but not out.Lancet 363, no. 9407 (February 7, 2004): 414–15. https://doi.org/10.1016/S0140-6736(04)15522-0.
Goldstein LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 7;363(9407):414–5.
Goldstein, Larry B. “Neuroprotective therapy for acute ischaemic stroke: down, but not out.Lancet, vol. 363, no. 9407, Feb. 2004, pp. 414–15. Pubmed, doi:10.1016/S0140-6736(04)15522-0.
Goldstein LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 7;363(9407):414–415.
Journal cover image

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

February 7, 2004

Volume

363

Issue

9407

Start / End Page

414 / 415

Location

England

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Research Design
  • Randomized Controlled Trials as Topic
  • Neuroprotective Agents
  • Magnesium Sulfate
  • Humans
  • General & Internal Medicine
  • Acute Disease
  • 42 Health sciences